SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001013594-17-000189
Filing Date
2017-02-14
Accepted
2017-02-14 17:38:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 FEBRUARY 14, 2017 sarepta13ga-021417.htm SC 13G/A 60029
  Complete submission text file 0001013594-17-000189.txt   61951
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Subject) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-54847 | Film No.: 17611019
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 SEVENTH AVENUE 32ND FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 32ND FLOOR NEW YORK NY 10019 212-554-2500
Tourbillon Capital Partners, L.P. (Filed by) CIK: 0001592476 (see all company filings)

IRS No.: 460724833 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A